Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07284641 · ClinicalTrials.gov registry record · Phase 2
Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)
A Phase 2 study of DiGeorge Syndrome and Immune Dysregulation, sponsored by Paul Szabolcs.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT07284641: Recruiting Phase 2 study of DiGeorge Syndrome and Immune Dysregulation, sponsored by Paul Szabolcs.
NCT07284641 is a Phase 2 study of DiGeorge Syndrome and Immune Dysregulation that is actively recruiting participants, run by Paul Szabolcs. The registered enrollment target is 25 participants, below the 447-participant average among 4 other DiGeorge Syndrome trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07284641, a Phase 2 study of DiGeorge Syndrome and Immune Dysregulation, is actively recruiting participants, sponsored by Paul Szabolcs.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a research protocol that will examine Hematopoietic Stem Cell Transplantation (HSCT) using a reduced conditioning regimen (RIC) with total body Irradiation (TBI) in those diagnosed with Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD).
Primary Outcome
review of the existing medical records to check on the participant's survival status
Conditions Studied
Interventions
- BIOLOGICAL Hematopoietic stem cell transplant (HSCT)
Study Locations (1)
Pennsylvania
- UPMC Children's Hospital of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-03-01 |
| Est. Completion | 2031-02-01 |
| Phase | Phase 2 |
What NCT07284641 shows while recruiting
NCT07284641 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 447-participant average among 4 other DiGeorge Syndrome trials with a reported enrollment target (94% lower).
The record links to 10 conditions, with DiGeorge Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Hematopoietic stem cell transplant (HSCT) is the first listed.
NCT07284641 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07284641 about?
NCT07284641 is a clinical study titled "Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)". This is a research protocol that will examine Hematopoietic Stem Cell Transplantation (HSCT) using a reduced conditioning regimen (RIC) with total body Irradiation (TBI) in those diagnosed with Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory D...
What is the current status of trial NCT07284641?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2026-03-01. Estimated completion is 2031-02-01.
What conditions does trial NCT07284641 study?
This clinical trial studies the following conditions: DiGeorge Syndrome, Immune Dysregulation, Primary Immune Regulatory Disorder, Common Variable Immunodeficiency (CVID), CD40 Ligand Deficiency.
What interventions are being tested in trial NCT07284641?
The interventions under investigation include: Hematopoietic stem cell transplant (HSCT) (BIOLOGICAL).
Who is sponsoring clinical trial NCT07284641?
This trial is sponsored by Paul Szabolcs, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07284641 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for DiGeorge Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI